Stephanie Davis

Stephanie Davis is a former senior associate editor of DVM Newsmagazine.

Articles by Stephanie Davis

New rules issued this summer are requiring 190,000 research and diagnostic laboratories, including veterinary facilities, to notify federal authorities if they are in possession of any of 36 "select" biological agents.

image1-31522-1384864112568.jpg

Albany, N.Y.-As the allure of pet-inclusive wills and health insurance saturates mainstream America, the New York State Bar Association (NYSBA) now welcomes such discussions in the courtroom.

Atlanta-After swallowing the financial side effects of the Food and Drug Administration's $500 million fine on Schering-Plough, a patent holder for canine "dry eye" medication is, in turn, slapping lawsuits on negligent compounding pharmacies.

Columbus-A leading veterinary neurologist, equally celebrated and denigrated for his progressive study of feline immunodeficiency virus (FIV), is departing The Ohio State University (OSU). Expected to leave this summer, Dr. Michael Podell - regarded as a "highly brilliant" veterinary clinician and investigator - says his decision to leave is three-fold,

Stroke setback didn't stop Kansas DVM from competing in grueling Boston Marathon; first stroke survivor to complete 'king of marathons'

It's not unusual for the Texas Veterinary Medical Diagnostic Laboratory (TVMDL) to receive numerous phone calls from the U.S. Department of Agriculture (USDA), but when it's the homeland security office a new sense of urgency emerges.

Bowling Green, Ky.-Food animal identification to promote food safety and disease outbreak prevention has been endorsed for years - if only the same were true for the horse industry, its proponents argue.

In May, the University of Kentucky (UK) released preliminary test results suggesting the eastern tent caterpillar and its waste remain chiefly responsible for increased foal losses in 2001, but the picture is "far from fully developed."

Three issues top newly appointed Food and Drug Administration (FDA) Deputy Commissioner Dr. Lester Crawford's agenda: bioterrorism, "intelligent" staffing and appropriate use of the FDA's whopping $1.6 billion budget.

Rockville, Md.-A recent Food and Drug Administration update warning that prescribing, purchasing, or distributing "compounded" clenbuterol violates federal law, is a first step to reform, indicate several DVMs.